Save time and get answers to complex questions with AI chat
Atorvastatin side effects heart palpitations?When is tenofovir alafenamide patent expiring?When did risperdal constas patent expire published article?Symbravo ingredients mechanism of action?Drugpatentwatch market analysis industry today?
See the DrugPatentWatch profile for xofluza
Xofluza (baloxavir marboxil) was developed by the Japanese pharmaceutical company Shionogi & Co., Ltd. In the United States it’s marketed by Genentech, a Roche subsidiary. Globally, Roche/Genentech handles many regional rights under a development/licensing arrangement with Shionogi.
Other Questions About Xofluza :